Combined efficacy of DPP-4 inhibitor in type 2 diabetic patients in the medical treatment of Sulfonylurea
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000010051
- Lead Sponsor
- Osaka Saiseikai Noe Hospital
- Brief Summary
The 55th Annual Meeting of the Japan Diabetes Society The 56th Annual Meeting of the Japan Diabetes Society
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with type 1 diabetes Patients with a history of severe ketosis, diabetic coma or pre-coma within the past six months Patients with severe infection, before and after surgery, or severe trauma Patients with moderate renal impairment or more(serum creatinine level:1.5mg/dl or more(male),1.3mg/dl or more(female)) Patients in the insulin therapy, rapid insulin secretagogue, or alpha-glucosidase inhibitor Patients with a planned pregnancy or likely to be pregnant or lactating patients, or pregnant patients Patients with a history of hypersensitivity to study drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method